Disease Info Card

Decreased Immunologic Activity [pe]

Information about Decreased Immunologic Activity [pe]: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Decreased Immunologic Activity [pe]

Most recent studies have shown that Decreased Immunologic Activity [pe] shares some biological mechanisms with acquired-immunodeficiency-syndrome, autoimmune-diseases, autoimmune-reaction, carcinoma, cytomegalovirus-infections, diabetes-mellitus, graft-vs-host-disease, hepatitis, hiv-infections, immunologic-deficiency-syndromes, infective-disorder, inflammation, kidney-diseases, kidney-failure-chronic, leukemia, lymphoma, malignant-neoplasms, neoplasms, pneumonia, virus-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Decreased Immunologic Activity [pe], and have been seen in publications frequently: Angiogenesis, Cell Activation, Cell Death, Cell Proliferation, Cytokine Production, Glomerular Filtration, Hypersensitivity, Immune Response, Inflammatory Response, Lymphocyte Proliferation, Pathogenesis, Phagocytosis, Regeneration, Secretion, Sensitization, T Cell Activation, T Cell Proliferation, Tolerance Induction, Viral Replication, Virulence

Quite a number of genes have been found to play important roles in Decreased Immunologic Activity [pe], such as CABIN1, CD2, CD4, CD8A, CTLA4, FOXP3, HLA-DQA1, HLA-E, IFNG, IL10, IL2, IL2RA, IL4, IL6, INS, ISG20, LBR, NOD2, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.